EMBCEmbecta Corp.

EMBC Stock Price, Valuation & Chart | Embecta Corp.

Compare

$6.270-0.18 (-2.79%)

At close · 16 Oct 2026, 08:00 pm

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Overview Financials Dividends Ratios

EMBC Historical price chart

EMBC Key Stats

Market Capitalization355.26M

PE Ratio2.41

EPS2.6

Trading Volume622.66K

Today's High/Low6.53/6.26

Dividend Yield5.10

52 Week High/Low14.91/2.77

Shares Outstanding56.66M

EMBC Financial Statement

EMBC Analyst ratings

EMBC Analysis & performance metrics

EMBC Company profile

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products…

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United…

EMBC Management team

Name

Position

Shaun Curtis

Senior Vice President of Global Manufacturing & Supply Chain

Jacob P. ElguiczeCFO

Senior Vice President & Chief Financial Officer

Jeffrey Z. Mann

Senior Vice President, General Counsel, Head of Business Development & Corporate Secretary

Jean M. Casner

Senior Vice President & Chief Human Resources Officer

Colleen RileyCTO

Senior Vice President & Chief Technology Officer

Tom Blount

Senior Vice President & President of North America

Devdatt Kurdikar Ph.D.CEO

President, Chief Executive Officer & Director

Anthony M. Roth

Vice President, Chief Accounting Officer & Corporate Controller

Name

Position

Shaun Curtis

Senior Vice President of Global Manufacturing & Supply Chain

Jacob P. ElguiczeCFO

Senior Vice President & Chief Financial Officer

Jeffrey Z. Mann

Senior Vice President, General Counsel, Head of Business Development & Corporate Secretary

Jean M. Casner

Senior Vice President & Chief Human Resources Officer

Colleen RileyCTO

Senior Vice President & Chief Technology Officer

Tom Blount

Senior Vice President & President of North America

Devdatt Kurdikar Ph.D.CEO

President, Chief Executive Officer & Director

Anthony M. Roth

Vice President, Chief Accounting Officer & Corporate Controller

Management Team

Shaun Curtis

Senior Vice President of Global Manufacturing & Supply Chain

Jacob P. ElguiczeCFO

Senior Vice President & Chief Financial Officer

Jeffrey Z. Mann

Senior Vice President, General Counsel, Head of Business Development & Corporate Secretary

Jean M. Casner

Senior Vice President & Chief Human Resources Officer

Colleen RileyCTO

Senior Vice President & Chief Technology Officer

Tom Blount

Senior Vice President & President of North America

Devdatt Kurdikar Ph.D.CEO

President, Chief Executive Officer & Director

Anthony M. Roth

Vice President, Chief Accounting Officer & Corporate Controller

Management

Shaun Curtis

Senior Vice President of Global Manufacturing & Supply Chain

Jacob P. ElguiczeCFO

Senior Vice President & Chief Financial Officer

Jeffrey Z. Mann

Senior Vice President, General Counsel, Head of Business Development & Corporate Secretary

Jean M. Casner

Senior Vice President & Chief Human Resources Officer

Colleen RileyCTO

Senior Vice President & Chief Technology Officer

Tom Blount

Senior Vice President & President of North America

Devdatt Kurdikar Ph.D.CEO

President, Chief Executive Officer & Director

Anthony M. Roth

Vice President, Chief Accounting Officer & Corporate Controller

Total 8 executives

EMBC Frequently asked questions

What is Embecta Corp. (EMBC) Stock Price?

Current stock price of Embecta Corp. (EMBC) stock is $6.270. The stock price is -2.79% lower in the session. The intraday range can be seen from this page. Volume of Embecta Corp. (EMBC) stock is 622.66K.

Last updated at 16 Oct 2026, 08:00 pm.

Why is the Embecta Corp. (EMBC) stock price going up or down today?

The stock price of Embecta Corp. (EMBC) can change with earnings, company news, and overall market sentiment. Embecta Corp. operates in the Healthcare / Drug Manufacturers - Specialty & Generic market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Embecta Corp. stock expensive at its current price?

Whether Embecta Corp. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for EMBC on this page is 2.41. EPS on this page is 2.60. Compare those figures with peers and growth expectations before deciding if the current Embecta Corp. price is justified.

How has the stock price of Embecta Corp. (EMBC) performed historically?

Historical performance for Embecta Corp. (EMBC) is shown on the price chart on this page. Review multi-period moves alongside volume to see how EMBC reacted to past earnings and market events.

Should I buy Embecta Corp. (EMBC) stock, at this price?

Buying Embecta Corp. (EMBC) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.